The FDA on Friday approved the first immunotherapy for any kind of breastcancer Roche\'s Tecentriq atezolizumab. httpsbuff.ly2H5918UÂ

The FDA on Friday approved the first immunotherapy for any kind of #breastcancer: Roche's Tecentriq (atezolizumab). https://buff.ly/2H5918U 

18:08 EST 8 Mar 2019 | STAT

The FDA on Friday approved the first immunotherapy for any kind of #breastcancer: Roche's Tecentriq (atezolizumab). https://buff.ly/2H5918U 

More From BioPortfolio on "The FDA on Friday approved the first immunotherapy for any kind of #breastcancer: Roche's Tecentriq (atezolizumab). https://buff.ly/2H5918U "